Karr Narula is a former partner at KKR and head of KKR's Portfolio Operations Team in the Americas.
Narula was with KKR from 2007 through 2020. He served as the Head of KKR's Portfolio Operations Team (KKR Capstone) in the Americas and was a member of KKR’s Americas Private Equity Portfolio Management Committee. He also led value creation efforts for KKR’s health care investing platform. In this role, he was involved in the development of investment themes, the early evaluation and due diligence of health care investments and the delivery of operational transformations within KKR’s health care portfolio companies. Additionally, he provided significant operational support and oversight in the launch of KKR’s health care growth equity investing efforts and sat on KKR’s Health Care Strategic Growth Portfolio Management Committee. During his time at KKR, Mr. Narula worked closely with KKR’s investments in Biomet, Intelligence, Harden Healthcare, Pharmaceutical Research Associates, Research Pharmaceutical Services, Air Medical Group Holdings, Panasonic Healthcare, Bayer Diabetes Care, Amedisys, Covenant Surgical Partners, PharMerica, BrightSpring Health Services, American Medical Response, and Envision Healthcare. He also served on the board of Blue Sprig Pediatrics. He holds a B.S. with distinction from Stanford University and an M.B.A. from Harvard Business School.